Lantheus Alpha Therapy, LLC sold $131K of CATX
Lantheus Alpha Therapy, LLC sold 42,129 shares of Perspective Therapeutics, Inc. (CATX) at $3.11 ($0.13M total) on 2026-09-02. Filed jointly with Lantheus Holdings, Inc. (10% owner).
How this was made
The 30-second read
Why it matters
The disclosed sale is a routine insider transaction with limited market impact.
Market read
Minor insider sell; unlikely to affect stock price materially.
What to watch
Potential upcoming corporate actions not disclosed.
Background
SEC Form 4 filing by Lantheus Alpha Therapy, LLC reporting an insider transaction for Perspective Therapeutics.
Ticker impact
Form 4 disclosed a 10% owner sold 42,129 shares for $131,219, reducing holdings to 11.5M shares.
No significant price impact expected.
The sale size is small relative to total shares and market cap; insider still holds >10%.
Market effects
None
None
None
Counterpoint
Insider sale could signal concerns, but size is trivial.
Key entities
- CompanyPerspective Therapeutics, Inc.
Biopharma company whose insider sold shares.
- InsiderLantheus Alpha Therapy, LLC
10% owner reporting the sale.